Sheng-li Xue, Md

This study tests whether the drug Inotuzumab can eliminate tiny amounts of returning cancer cells in patients with acute lymphoblastic leukemia (ALL) who have already undergone a stem cell transplant. The goal is to prevent a full cancer relapse and improve survival. Researchers …

This study is testing whether a combination of two drugs, venetoclax and azacitidine, can help people newly diagnosed with a rare and aggressive type of blood cancer called acute leukemia of ambiguous lineage. The goal is to see if this drug combo can put the cancer into remissio…